BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31857578)

  • 1. Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations.
    Inoue S; Hirota Y; Ueno T; Fukui Y; Yoshida E; Hayashi T; Kojima S; Takeyama R; Hashimoto T; Kiyono T; Ikemura M; Taguchi A; Tanaka T; Tanaka Y; Sakata S; Takeuchi K; Muraoka A; Osuka S; Saito T; Oda K; Osuga Y; Terao Y; Kawazu M; Mano H
    Nat Commun; 2019 Dec; 10(1):5785. PubMed ID: 31857578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenomyosis pathogenesis: insights from next-generation sequencing.
    Bulun SE; Yildiz S; Adli M; Wei JJ
    Hum Reprod Update; 2021 Oct; 27(6):1086-1097. PubMed ID: 34131719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone and synthetic progestin, dienogest, induce apoptosis of human primary cultures of adenomyotic stromal cells.
    Yamanaka A; Kimura F; Kishi Y; Takahashi K; Suginami H; Shimizu Y; Murakami T
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():170-4. PubMed ID: 24953822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometriosis and adenomyosis: shared pathophysiology.
    Bulun SE; Yildiz S; Adli M; Chakravarti D; Parker JB; Milad M; Yang L; Chaudhari A; Tsai S; Wei JJ; Yin P
    Fertil Steril; 2023 May; 119(5):746-750. PubMed ID: 36925057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted next-generation sequencing for the detection of cancer-associated somatic mutations in adenomyosis.
    Chao A; Wu RC; Lin CY; Lee LY; Tsai CL; Lee YS; Wang CJ
    J Obstet Gynaecol; 2023 Dec; 43(1):2161352. PubMed ID: 36708516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells.
    Ichioka M; Mita S; Shimizu Y; Imada K; Kiyono T; Bono Y; Kyo S
    J Steroid Biochem Mol Biol; 2015 Mar; 147():103-10. PubMed ID: 25533385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
    Liu X; Shen M; Qi Q; Zhang H; Guo SW
    Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest.
    Takagi H; Takakura M; Sasagawa T
    Taiwan J Obstet Gynecol; 2023 Nov; 62(6):852-857. PubMed ID: 38008504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron overload inhibits cell proliferation and promotes autophagy via PARP1/SIRT1 signaling in endometriosis and adenomyosis.
    Zhou Y; Zhao X; Zhang L; Xia Q; Peng Y; Zhang H; Yan D; Yang Z; Li J
    Toxicology; 2022 Jan; 465():153050. PubMed ID: 34826546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation and methylation profiles of ectopic and eutopic endometrial tissues.
    Li L; Antero MF; Zhang M; Chu T; Seckin T; Ayhan A; Pisanic T; Wang TL; Cope L; Segars J; Shih IM
    J Pathol; 2021 Dec; 255(4):387-398. PubMed ID: 34396532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis.
    Takeuchi A; Koga K; Miyashita M; Makabe T; Sue F; Harada M; Hirata T; Hirota Y; Fujii T; Osuga Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():157-161. PubMed ID: 27865118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the safety of dienogest in women with adenomyosis: A retrospective analysis.
    Ono N; Asano R; Nagai K; Sugo Y; Nakamura T; Miyagi E
    J Obstet Gynaecol Res; 2021 Apr; 47(4):1433-1440. PubMed ID: 33590656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-Associated Mutations in Endometriosis without Cancer.
    Anglesio MS; Papadopoulos N; Ayhan A; Nazeran TM; Noë M; Horlings HM; Lum A; Jones S; Senz J; Seckin T; Ho J; Wu RC; Lac V; Ogawa H; Tessier-Cloutier B; Alhassan R; Wang A; Wang Y; Cohen JD; Wong F; Hasanovic A; Orr N; Zhang M; Popoli M; McMahon W; Wood LD; Mattox A; Allaire C; Segars J; Williams C; Tomasetti C; Boyd N; Kinzler KW; Gilks CB; Diaz L; Wang TL; Vogelstein B; Yong PJ; Huntsman DG; Shih IM
    N Engl J Med; 2017 May; 376(19):1835-1848. PubMed ID: 28489996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association of Sonographic Evidence of Adenomyosis with Severe Endometriosis and Gene Expression in Eutopic Endometrium.
    Dior UP; Nisbet D; Fung JN; Foster G; Healey M; Montgomery GW; Rogers PAW; Holdsworth-Carson SJ; Girling JE
    J Minim Invasive Gynecol; 2019; 26(5):941-948. PubMed ID: 30273686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium.
    Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Tamura R; Mori Y; Yamawaki K; Adachi S; Takahashi T; Kase H; Tanaka K; Yamamoto T; Motoyama T; Inoue I; Enomoto T
    Cell Rep; 2018 Aug; 24(7):1777-1789. PubMed ID: 30110635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of dienogest over 53 weeks for the treatment of endometriosis.
    Sugimoto K; Nagata C; Hayashi H; Yanagida S; Okamoto A
    J Obstet Gynaecol Res; 2015 Dec; 41(12):1921-6. PubMed ID: 26369271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.
    Szubert M; Kozirog E; Wilczynski J
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study.
    Hirata T; Izumi G; Takamura M; Saito A; Nakazawa A; Harada M; Hirota Y; Koga K; Fujii T; Osuga Y
    Gynecol Endocrinol; 2014 Oct; 30(10):726-9. PubMed ID: 24905725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenomyosis: single-cell transcriptomic analysis reveals a paracrine mesenchymal-epithelial interaction involving the WNT/SFRP pathway.
    Yildiz S; Kinali M; Wei JJ; Milad M; Yin P; Adli M; Bulun SE
    Fertil Steril; 2023 May; 119(5):869-882. PubMed ID: 36736810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heavy uterine bleeding in women with endometriosis and adenomyosis treated with dienogest.
    Chou FW; Chang WH; Wang PH
    Taiwan J Obstet Gynecol; 2024 Mar; 63(2):139-140. PubMed ID: 38485301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.